Tower Research Capital LLC (Trc) Sutro Biopharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 24,017 shares of STRO stock, worth $22,816. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,017
Previous 24,879
3.46%
Holding current value
$22,816
Previous $17,000
23.53%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding STRO
# of Institutions
92Shares Held
57.3MCall Options Held
75KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$6.57 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$6.16 Million0.17% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.09MShares$4.83 Million0.38% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$4.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$3.5 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $49.6M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...